IL91370A - Alpha subunit of CAM-1 leukocyte adhesion receptor and its history, free from natural infections and pharmaceutical preparations containing them - Google Patents

Alpha subunit of CAM-1 leukocyte adhesion receptor and its history, free from natural infections and pharmaceutical preparations containing them

Info

Publication number
IL91370A
IL91370A IL9137089A IL9137089A IL91370A IL 91370 A IL91370 A IL 91370A IL 9137089 A IL9137089 A IL 9137089A IL 9137089 A IL9137089 A IL 9137089A IL 91370 A IL91370 A IL 91370A
Authority
IL
Israel
Prior art keywords
mac
subunit
alpha
functional derivative
sequence
Prior art date
Application number
IL9137089A
Other languages
English (en)
Hebrew (he)
Other versions
IL91370A0 (en
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of IL91370A0 publication Critical patent/IL91370A0/xx
Publication of IL91370A publication Critical patent/IL91370A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9137089A 1988-08-23 1989-08-21 Alpha subunit of CAM-1 leukocyte adhesion receptor and its history, free from natural infections and pharmaceutical preparations containing them IL91370A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23535388A 1988-08-23 1988-08-23
US32123989A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
IL91370A0 IL91370A0 (en) 1990-04-29
IL91370A true IL91370A (en) 1995-07-31

Family

ID=26928829

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9137089A IL91370A (en) 1988-08-23 1989-08-21 Alpha subunit of CAM-1 leukocyte adhesion receptor and its history, free from natural infections and pharmaceutical preparations containing them

Country Status (13)

Country Link
US (3) US5849896A (fr)
EP (1) EP0364690A3 (fr)
JP (1) JPH0347077A (fr)
KR (1) KR0185964B1 (fr)
AU (1) AU638937B2 (fr)
CA (1) CA1341293C (fr)
DK (1) DK412489A (fr)
FI (1) FI893917A (fr)
HU (1) HU213014B (fr)
IL (1) IL91370A (fr)
NO (1) NO893367L (fr)
NZ (1) NZ230397A (fr)
PT (1) PT91502B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303692A4 (en) * 1987-02-26 1990-12-05 Dana Farber Cancer Institute Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US5877275A (en) * 1988-06-28 1999-03-02 The General Hospital Corporation Controlling cellular immune/inflammatory responses with β2 integrins
EP0364690A3 (fr) 1988-08-23 1990-07-18 Dana Farber Cancer Institute Sous-unité du récepteur d'adhésion de leukocyte Mac-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
CA2050326A1 (fr) * 1989-03-09 1990-09-10 Angel A. Corbi Recepteurs d'adhesion des leucocytes
JPH04505009A (ja) * 1989-03-09 1992-09-03 ダナ・ファーバー・キャンサー・インスティチュート クローニングｌｆａ―１
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
EP0670734A4 (fr) * 1992-10-09 1998-01-14 Blood Res Center SOUS-POPULATION DE MOLECULES Mac-1 (CD11B/CD 18) QUI INDUISENT L'ADHESION NEUTROPHILE A ICAM-1 ET AU FIBRINOGENE.
AU2355895A (en) * 1994-04-26 1995-11-16 Pharmacia & Upjohn Company Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
ATE237342T1 (de) * 1994-07-11 2003-05-15 Athena Neurosciences Inc Inhibitoren der leukozytenadhäsion
US5696229A (en) * 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
US6037454A (en) * 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
US7400477B2 (en) 1998-08-24 2008-07-15 Leviton Manufacturing Co., Inc. Method of distribution of a circuit interrupting device with reset lockout and reverse wiring protection
US6210897B1 (en) 1999-05-26 2001-04-03 Leif Andersson Identification of canine leukocyte adhesion deficiency in dogs
AU4574501A (en) 2000-03-17 2001-10-03 Millennium Pharm Inc Method of inhibiting stenosis and restenosis
US7160541B2 (en) 2000-09-01 2007-01-09 The Center For Blood Research, Inc. Modified polypeptides stabilized in a desired conformation and methods for producing same
US7372678B2 (en) * 2005-08-24 2008-05-13 Leviton Manufacturing Co., Inc. Circuit interrupting device with automatic test
US7852606B2 (en) * 2005-08-24 2010-12-14 Leviton Manufacturing Company, Inc. Self-testing circuit interrupting device
US7911746B2 (en) * 2006-06-01 2011-03-22 Leviton Manufacturing Co., Inc. GFCI with self-test and remote annunciation capabilities
US8603628B2 (en) * 2007-04-30 2013-12-10 Saint-Gobain Performance Plastics Corporation Turbine blade protective barrier
CA2711903C (fr) 2008-01-29 2019-01-15 Leviton Manufacturing Co., Inc. Appareil et procede d'interrupteur de circuit detecteur de defaut a autocontrole
US9759758B2 (en) 2014-04-25 2017-09-12 Leviton Manufacturing Co., Inc. Ground fault detector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US5424399A (en) * 1988-06-28 1995-06-13 The Children's Medical Center Corporation Human CR3α/β heterodimers
EP0364690A3 (fr) 1988-08-23 1990-07-18 Dana Farber Cancer Institute Sous-unité du récepteur d'adhésion de leukocyte Mac-1

Also Published As

Publication number Publication date
PT91502A (pt) 1990-03-08
US5849896A (en) 1998-12-15
HUT54207A (en) 1991-01-28
DK412489A (da) 1990-02-24
IL91370A0 (en) 1990-04-29
AU4014489A (en) 1990-03-01
FI893917A0 (fi) 1989-08-21
NO893367L (no) 1990-02-26
US6683158B2 (en) 2004-01-27
EP0364690A2 (fr) 1990-04-25
KR900002797A (ko) 1990-03-23
NO893367D0 (no) 1989-08-22
US20020022595A1 (en) 2002-02-21
HU213014B (en) 1997-01-28
KR0185964B1 (ko) 1999-05-01
PT91502B (pt) 1995-05-04
US20030013850A1 (en) 2003-01-16
EP0364690A3 (fr) 1990-07-18
DK412489D0 (da) 1989-08-22
AU638937B2 (en) 1993-07-15
JPH0347077A (ja) 1991-02-28
FI893917A (fi) 1990-02-24
CA1341293C (fr) 2001-09-18
NZ230397A (en) 1997-07-27

Similar Documents

Publication Publication Date Title
US5849896A (en) α-subunit of the Mac-1 leukocyte adhesion receptor
EP0362526B1 (fr) Sous-unité du récepteur d'adhésion de leucocyte LFA-1
Corbi et al. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B.
DK175362B1 (da) Oplöseligt funktionelt derivat af ICAM-1, rekombinant DNA-molekyle og fremgangsmåde til fremstilling af nævnte derivat, farmaceutisk præparat indeholdende et sådant derivat og derivatets anvendelse til fremstilling af et sådant præparat, samt....
IL86246A (en) Intercellular adhesion molecules and functional derivatives thereof, their production and antibodies against thereto
EP0387668A1 (fr) Molécule d'adhésion intercellulaire-2 et ses ligands de liaisons
NO317658B1 (no) Intercellulært adhesjonsmolekyl-3 og dets bindingsligander
EP0606518B1 (fr) Molécules d'adhésion intercellulaire et leurs ligands de liaison
US5686265A (en) Leukocyte adhesion receptors
US5629162A (en) Method of identifying agents which modulate ICAM-3 binding to LFA-1
WO1991019511A1 (fr) LUTTE CONTRE LES REACTIONS IMMUNITAIRES/INFLAMMATOIRES CELLULAIRES DES INTEGRINES β2
WO1990010646A1 (fr) Recepteurs d'adherence de leucocyte
US5877275A (en) Controlling cellular immune/inflammatory responses with β2 integrins
AU670243C (en) Intercellular adhesion molecule-3 and its binding ligands
NZ244853A (en) Antibodies and fragments to icam-1, pharmaceutical composition

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired